Acquist Therapeutics Expands Patent Portfolio for Novel Small Molecules, Receives Fourth U.S. Composition Patent
- Tuesday, April 21, 2020, 7:06
- Finance
- Add a comment
CHATHAM, N.J., April 21, 2020 /PRNewswire/ — Acquist Therapeutics, Inc., a biopharmaceutical company committed to discovery of new treatments for people with inflammatory diseases, today announced that the Company received a fourth patent from the U.S. Patent Office that covers the…
About the Author
adminasapcorp has written 41555 stories on this site.